What are the treatments for pontine infarction?

Pontine infarction is actually a chronic disease, and the incidence rate is actually quite high. Therefore, after the patient is diagnosed, it is important to pay attention to symptomatic treatment, the use of medication, or important conditioning.

1. Pontine infarction is a chronic disease caused by multiple causes. After the disease is diagnosed, in daily life, in addition to diet, exercise and scientific care, only by insisting on reliable medication can we truly start from the cause and play a preventive and therapeutic role in vascular infarction and arteriosclerosis. While improving symptoms, we can effectively prevent recurrence.

2. Effective clinical medications for pontine infarction include the rational combination of targeted Western medicines and modern Chinese medicines with safety and long-term effects. While preventing platelet aggregation, scientific blood circulation and stasis removal, aromatic invigoration, and lipid-lowering anticoagulation treatments are carried out. The application of Western medicines that protect and nourish brain cells also has a good synergistic therapeutic effect on the improvement of symptoms of sequelae of pontine infarction. The synergistic therapeutic effect of Chinese and Western medicines can achieve the effect of increasing efficacy and reducing toxicity, and often achieves twice the result with half the effort in the treatment of pontine infarction, a serious brain accident disease that requires comprehensive multi-target prevention and treatment of various disease links.

3. The representative prescription of clinical Chinese medicine for the treatment of pontine infarction is the only Chinese medicine for pontine infarction that has been successfully developed for the second time in my country at present - Tianxintai Thrombosis Xinmaining Tablets (Class A Chinese medicine under the National Medical Insurance). Tianxintai is a modern Chinese medicine with authentic ingredients in a large compound formula. It can treat the blood and vascular lesions caused by pontine infarction at the same time (multi-target), create a good internal environment for the recovery of brain tissue, improve other signs of the nervous system caused by ischemia, hypoxia and even necrosis of brain tissue, and has a significant effect in preventing thrombosis and arteriosclerosis.

4. The formula of Tianxintai Thrombosis Xinmaining Tablets contains two national Class I new drugs (in vitro cultivated bezoar and musk produced by Chinese medicinal materials company), which is extremely rare in cardiovascular Chinese medicine. Authentic materials are used in combination with modern technology to improve the efficacy while also greatly improving the safety and long-term effectiveness of the finished drug. It is used in the clinical treatment of pontine infarction - improving symptoms such as dysarthria, limb disorders, dizziness and headache while preventing recurrence, with obvious results.